Studies showed that, in vitro, VTN inhibits β-amyloid aggregation to form a fibrous amyloid [18], which is the main feature of Alzheimer’s disease (AD). The gene discussed is VTN; the disease is early-onset autosomal dominant Alzheimer disease.